The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...
Exton, PA, June 15, 2023 (GLOBE NEWSWIRE) -- Systemic lupus erythematosus (SLE) patients present significant challenges in management, given the complexity of the condition and few effective treatment ...
Weight-based dosing misses accounting for factors such as chronic kidney disease or chronic transaminitis, which could ...
The implementation of a decision aid for systemic lupus erythematosus (SLE) in US clinics improved patient outcomes, including reduced decisional conflict and enhanced shared decision-making. Over 80% ...
Atherosclerosis was once believed to be caused by passive deposition of lipids into arterial walls, with subsequent covering of the deposits by smooth muscle and endothelial cells; however, we now ...
Thrombotic microangiopathy further decreases patient and renal survival in patients with SLE. Patients with systemic lupus erythematosus (SLE) with thrombotic microangiopathy (TMA) have lower ...
Baseline factors including age, race, and steroid use were predictive of flare in patients with systemic lupus erythematosus (SLE) who tapered or discontinued treatment with hydroxychloroquine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results